Edoxaban zur Schlaganfallprophylaxe bei Patienten mit nicht-valvulärem Vorhofflimmern und zur Behandlung venöser Thromboembolien: ein interdisziplinäres Positionspapier [PDF]
, 2017 Thomas W. Weiss +7 more
openalex +1 more source
DEN OpenObjectives There are limited reports on the safety of gastrointestinal endoscopic procedures in individuals taking edoxaban, one of the direct oral anticoagulants.
Ken‐ichi Mizuno +9 more
doaj +1 more source
Direct oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolism [PDF]
, 2017 Direct oral anticoagulants (DOACs) specifically target factor IIa or Xa and represent a major step forward in the treatment of acute- and long-term prevention of venous thrombo-embolism (VTE).
Bounameaux, Henri +2 more
core
UEG Week 2025 Moderated Posters
United European Gastroenterology Journal, Volume 13, Issue S8, Page S189-S802, October 2025.
wiley +1 more source
Anticoagulation Control in Warfarin -Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin – Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial) [PDF]
, 2017 Gregory Y.H. Lip +7 more
openalex +1 more source
Edoxaban, a direct oral factor Xa inhibitor, ameliorates coagulation, microvascular thrombus formation, and acute liver injury in a lipopolysaccharide-induced coagulopathy model in rats [PDF]
, 2021 Y Morishima +4 more
openalex +1 more source
Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal [PDF]
, 2016 core +1 more source
UEG Week 2025 Poster Presentations
United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley +1 more source
Annualized clinical event rates during two-year follow-up are low in 27,617 atrial fibrillation patients on edoxaban: results from the global noninterventional ETNA-AF program [PDF]
, 2021 Leon Dinshaw +12 more
openalex +1 more source